Parietal epithelia cells in the urine as a marker of disease activity in glomerular diseases
Authors:
- 16 June 2008
- journal article
- Published by Oxford University Press (OUP) in Nephrology Dialysis Transplantation
- Vol. 23 (10) , 3138-3145
Abstract
Background. The detection of viable podocytes in the urine of patients with proteinuric diseases has been described as a non-invasive method to monitor disease activity. Most of the published studies use podocalyxin (PDX) as a podocyte specific marker.Keywords
This publication has 25 references indexed in Scilit:
- CD2AP/CIN85 Balance Determines Receptor Tyrosine Kinase Signaling Response in PodocytesJournal of Biological Chemistry, 2007
- Expression profile of nephrin, podocin, and CD2AP in Chinese children with MCNS and IgA nephropathyPediatric Nephrology, 2006
- IGF-Binding Protein-3 Modulates TGF-β/BMP-Signaling in Glomerular PodocytesJournal of the American Society of Nephrology, 2006
- Activated parietal epithelial cells or dedifferentiated podocytes in FSGS: Can we make the difference?Kidney International, 2006
- Podocytes that detach in experimental membranous nephropathy are viable11See Editorial by Mundel, p. 1529.Kidney International, 2003
- Podocyte is the major culprit accounting for the progression of chronic renal diseaseMicroscopy Research and Technique, 2002
- The Urinary Podocyte as a Marker for the Differential Diagnosis of Idiopathic Focal Glomerulosclerosis and Minimal-Change Nephrotic SyndromeAmerican Journal of Nephrology, 2000
- Podocalyxin on the Glomerular Epithelial Cells Is Preserved Well in Various Glomerular DiseasesNephron, 1994
- Immunoelectron microscopy in kidney research: Some contributions and limitationsKidney International, 1986
- Identification and characterization of podocalyxin--the major sialoprotein of the renal glomerular epithelial cell.Journal of Cell Biology, 1984